Skip to main content

Table 6 TIL scores regarding the hormonal and HER2 receptor expression states

From: Characterization of immune checkpoints expression and lymphocyte densities of iranian breast cancer patients; the co-expression status and clinicopathological associates

 

Mean (SD)

Median (IQR)

P value

ER

  

0.003

Negative

22.28 (20.56)

12.5 (25)

Positive

15.76 (17.11)

10 (15)

PR

  

0.029

Negative

20.40 (19.98)

10 (25)

Positive

15.98 (17.20)

10 (22.5)

HER2

  

0.005

Negative

15.59 (17.03)

10 (15)

Positive

24.23 (21.21)

20 (35)

equivocal

11.52 (11.30)

10 (6)

  1. TIL, tumor-infiltrating lymphocytes; HER2, human epidermal growth factor receptor 2; SD, standard deviation; IQR, interquartile range; ER, estrogen receptor; PR, progesterone receptor